Exploiting the defensive sugars of HIV-1 for drug and vaccine design
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...
Auteurs principaux: | Scanlan, C, Offer, J, Zitzmann, N, Dwek, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Nature Research
2007
|
Documents similaires
-
Emerging principles for the therapeutic exploitation of glycosylation.
par: Dalziel, M, et autres
Publié: (2014) -
Sugar immunogens
par: Dwek, R, et autres
Publié: (2009) -
Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
par: Dunlop, D, et autres
Publié: (2008) -
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
par: Dunlop, D, et autres
Publié: (2008) -
Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
par: Dunlop, D, et autres
Publié: (2009)